Diabetes affects many body parts, including the eyes. Vision-threatening Diabetic Retinopathy (VTDR) is a major eye disease that can compromise the normal vision. High incidence of other retinal eye disorders such as amblyopia, retinal detachment, and macular degeneration can impel demand for various retinal surgery devices.
Sight for the Sore Eyes
Bausch + Lomb announced the launch of Illuminated Directional Laser Probe, in late 2016. This probe uses a patented moving tube technology to adjust from straight to curve of up to 85 degrees. This can enable penetration of the surgical equipment in a straight angle. This can reduce the risk of damage to the natural eye lens. This laser probe can allow them to work around the posterior eye pole during laser surgery.
Ergonomically designed slide button of this probe can help surgeons to adjust its positioning from curved to straight while performing the surgery. Illumination technology can aid them to perform scleral depression with extreme edges. Midfield illumination pattern of this probe is compatible with most modern and ophthalmic lights. The recessed nature and moving design of the tube can maintain the required distance between illumination pattern and the eye without extending the laser fiber towards the retina.
According to a new report by Grand View Research, Inc.; the worldwide retinal surgery devices market is expected reach around USD 3.6 billion by 2025. It is predicted to grow at nearly 7.8% CAGR during the forecast period (2014 to 2025). High prevalence of diabetic retinopathy triggered by rising cases of diabetes can propel the market growth in the forthcoming years.
Baush & Lomb Incorporated; IRIDEX Corporation; and Synergetics, Inc.; are some of the key players operating in the global market. Most companies participate in strategic mergers & acquisitions, regional expansions, and novel product launches to sustain the stern competition within the market.
In-Depth research report on retinal surgery devices: